Skip to content

Change in Severity and Clinical Manifestation of MIS-C Over SARS-CoV-2 Variant Outbreaks in Korea

Document Type
Publications · Journal Article
Registered DB
KCISCIEScopus
Journal Ranking
JCR Q2Scopus Q1KCI Q1
Citation
Web of Science 15Scopus 15KCI 1
FWCI (Scopus)
1.93
JCR IF
JCR 2022 4.5
ISSN
1011-8934

Authors

  1. Choe, Young JuneFirst authorKorea Univ, Anam Hosp, Dept Pediat, Seoul, South Korea
  2. Choi, Eun HwaCorresponding authorSeoul Natl Univ, Coll Med, Dept Pediat, Seoul, South Korea
  3. Choi, Jong WoonBundang Jesaeng Gen Hosp, Dept Pediat, Seongnam, South Korea
  4. Eun, Byung WookNowon Eulji Univ Hosp, Dept Pediat, Seoul, South Korea
  5. Eun, Lucy YoungminYonsei Univ, Coll Med, Dept Pediat, Seoul, South Korea
  6. Kim, Yae-JeanKyungpook Natl Univ, Sch Med, Dept Pediat, Daegu, South Korea
  7. Kim, Yeo HyangSungkyunkwan Univ, Sch Med, Dept Pediat, Seoul, South Korea
  8. Kim, Young APusan Natl Univ, Sch Med, Dept Pediat, Yangsan, South Korea
  9. Kim, Yun-KyungKorea Univ, Dept Pediat, Coll Med, Seoul, South Korea
  10. Kwak, Ji HeeKangbuk Samsung Hosp, Dept Pediat, Seoul, South Korea
  11. Lee, HyukminYonsei Univ, Coll Med, Dept Lab Med, Seoul, South Korea
  12. Park, June DongSeoul Natl Univ, Coll Med, Dept Pediat, Seoul, South Korea
  13. Jung, Yeon HawYonsei Univ, Coll Med, Dept Lab Med, Seoul, South Korea
  14. Gwack, JinKorea Dis Control & Prevent Agcy, Gen Publ Hlth Emergency Preparedness, Cheongju, South Korea
  15. Lee, SangwonKorea Dis Control & Prevent Agcy, Gen Publ Hlth Emergency Preparedness, Cheongju, South Korea
  16. MIS C Surveillance Grp

Abstract

BACKGROUND: There is difference in the incidence of multi-system inflammatory syndrome in children (MIS-C) in patients with different variants of severe acute respiratory syndrome coronavirus 2, however, little is known about the epidemiology in Asian countries. We investigated and compared the epidemiology of the MIS-C during omicron-dominant period with that of previous periods in South Korea. METHODS: We obtained clinical, epidemiological and laboratory data on MIS-C cases from national MIS-C surveillance in South Korea. We defined pre-delta period as January 2020-May 2021; delta period as June 2021-December 2021; and omicron period as January 2022-April 2022. We describe the clinical characteristics and outcomes of MIS-C patients by period. RESULTS: A total of 91 cases were assessed to be MIS-C cases. Number of MIS-C cases have increased from six cases during pre-delta period to 66 cases during omicron period, while the incidence rate (the number of MIS-C cases per 100,000 cases of reported coronavirus disease 2019) has decreased from 38.5 cases per 100,000 (95% confidence interval [CI], 14.1-83.9) during pre-delta period to 1.6 cases per 100,000 (95% CI, 1.2-2.0) during omicron periods. During pre-delta period, 66.7% and 100% had hypotension and gastrointestinal involvement, respectively; while during omicron period, 12.1% and 6.1% had such clinical manifestations. Fifty percent of pre-delta MIS-C patients were taken intensive care unit (ICU) cares, while 10.6% of patients during omicron periods were in ICUs. CONCLUSION: Omicron period were associated with less severe clinical manifestation compared to pre-delta and delta periods. Although incidence rate of MIS-C was lower for the omicron period than pre-delta and delta periods, number of patients reported with MIS-C may pose a substantial clinical burden.

Keywords

COVID-19MIS-CSARS-CoV-2MULTISYSTEM INFLAMMATORY SYNDROMEOMICRON VARIANTSOUTH-KOREADISEASECHILDRENSURVEILLANCEVACCINE

Identifiers

Scopus EID
2-s2.0-85166105269
WoS UID
001043974700004
KCI
ART002983510